Dr. Renno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6901 N 72nd St
Suite 2244
Omaha, NE 68122Phone+1 402-572-3535Fax+1 402-572-2688
Summary
- Dr. Samer Renno is an oncologist in Omaha, NE and is affiliated with multiple hospitals in the area, including CHI Health Immanuel, Crawford County Memorial Hospital, Methodist Jennie Edmundson Hospital, CHI Health Creighton University Medical Center - Bergan Mercy, Columbus Community Hospital, Memorial Community Hospital and Health System, Nebraska Medicine - Nebraska Medical Center, Nebraska Methodist Hospital, Faith Regional Health Services, Nebraska Spine Hospital, and CHI Health Mercy Council Bluffs. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 21 years. He is experienced in hematologic oncology, thrombotic disorders, stem cell transplantation, bleeding disorders, and myeloproliferative disease.
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
University of Kansas (Wichita)Residency, Internal Medicine, 1996 - 1999
American University of Beirut Faculty of MedicineClass of 1996
Certifications & Licensure
NE State Medical License 2002 - 2026
IA State Medical License 1997 - 2025
NC State Medical License 1999 - 2003- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Publications & Presentations
PubMed
- 139 citationsEfficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.Ravi D. Rao, Patrick J. Flynn, Jeff A. Sloan, Gilbert Y. Wong, Paul J. Novotny
Cancer. 2008-06-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
